Kymera Therapeutics, Inc.
Clinical trials sponsored by Kymera Therapeutics, Inc., explained in plain language.
-
New pill for eczema shows promise in early trial
Symptom relief CompletedThis early-stage study tested an oral medication called KT-621 in 22 adults with moderate to severe atopic dermatitis (eczema). The main goal was to check safety and how the body processes the drug. Researchers also looked for signs that the drug might help control the condition,…
Phase: PHASE1 • Sponsor: Kymera Therapeutics, Inc. • Aim: Symptom relief
Last updated May 19, 2026 11:59 UTC
-
Healthy volunteers help test first doses of experimental drug KT-621
Knowledge-focused CompletedThis early-stage study tested the safety of a new oral drug, KT-621, in 118 healthy adults aged 19 to 55. Participants received either the drug or a placebo to check for side effects and how the drug moves through the body. The goal was not to treat any disease, but to gather ess…
Phase: PHASE1 • Sponsor: Kymera Therapeutics, Inc. • Aim: Knowledge-focused
Last updated May 15, 2026 11:56 UTC